FY2025 · period end May '25 · from the 10-K filed Jul 21, 2025
| Metric | FY25May '25 | FY24May '24 | FY23May '23 | FY22May '22 | FY21May '21 |
|---|---|---|---|---|---|
| Revenue | $87.93B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001104659-26-082672 | Jul 10, 2026 | Jul 10, 2026 | Jul 10, 2026 16:29 UTC | EDGAR |
| 8-K | 0001104659-26-077558 | Jun 25, 2026 | Jun 25, 2026 | Jun 25, 2026 12:38 UTC | EDGAR |
| 8-K | 0001048911-26-000050 | Jun 23, 2026 | Jun 23, 2026 | Jun 23, 2026 20:07 UTC | EDGAR |
| 8-K | 0001104659-26-071411 | Jun 8, 2026 | Jun 8, 2026 | Jun 8, 2026 20:34 UTC | EDGAR |
| 8-K | 0001104659-26-068519 | May 28, 2026 | Jun 1, 2026 | Jun 1, 2026 10:42 UTC | EDGAR |
| 8-K | 0001104659-26-065767 | May 22, 2026 | May 22, 2026 | May 22, 2026 20:33 UTC | EDGAR |
| 8-K | 0001104659-26-063198 | May 14, 2026 | May 18, 2026 | May 18, 2026 20:15 UTC | EDGAR |
| 8-K | 0001104659-26-060233 | May 11, 2026 | May 13, 2026 | May 13, 2026 20:06 UTC | EDGAR |
Direct links to SEC EDGAR. FDX has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·FY 2013
Major restatementwas$2.5B
Revised up in a 10-K.
Net Income (Loss) Available to Common Stockholders, Basic·FY 2013
Major restatementwas$1.6B
Revised up in a 10-K.
Net Income (Loss) Available to Common Stockholders, Diluted·FY 2013
Major restatementwas$1.6B
Revised up in a 10-K.
Net Income (Loss) Attributable to Parent·Q3 2014
Major restatementwas$378M
Revised up in a 10-K. Any P/E built on the original was 13.5% too high.
Operating Income (Loss)·Q3 2018
Major restatementwas$1B
Revised down in a 10-K.
Operating Income (Loss)·Q1 2017
Major restatementwas$1.1B
Revised down in a 10-K.
FDX is not the only one.
See every restatement we've found across the market — or get an alert the next time FDX revises a number.
Restatements are detected by comparing every vintage of a fact across all of FEDEX CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows FDX's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling FEDEX CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on FDX yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on FDX and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $90.16B |
| $93.51B |
| $83.96B |
| Gross Profit | — | — | — | — | — |
|---|
| Operating Income | $5.22B | $5.56B | $4.91B | $6.25B | $5.86B |
|---|
| Net Income | $4.09B | $4.33B | $3.97B | $3.83B | $5.23B |
|---|
| EPS (Diluted) | $16.81 | $17.21 | $15.48 | $14.33 | $19.45 |
|---|
| Metric | FY25May '25 | FY24May '24 | FY23May '23 | FY22May '22 | FY21May '21 |
|---|---|---|---|---|---|
| Total Assets | $87.63B | $87.01B | $87.14B | $85.99B | $82.78B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $28.07B | $27.58B | $26.09B | $24.94B | $24.17B |
| Cash & Equivalents | $5.50B | $6.50B | $6.86B | $6.90B | $7.09B |
| Total Debt | $19.15B | $20.14B | $20.45B | $20.18B | $20.73B |
| Metric | FY25May '25 | FY24May '24 | FY23May '23 | FY22May '22 | FY21May '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $7.04B | $8.31B | $8.85B | $9.83B | $10.13B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25May '25 | FY24May '24 | FY23May '23 | FY22May '22 | FY21May '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% |
| Return on Equity | 14.7% | 16.1% | 15.6% | 15.6% | 24.6% |
| Return on Assets | 4.7% | 5.0% | 4.6% | 4.5% | 6.7% |
| Debt / Equity | 0.72× | 0.73× | 0.78× | 0.81× | 0.86× |
